Charles Schwab’s Akcea Therapeutics, Inc. Common Stock AKCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-110,837
| Closed | -$2.01M | – | 3442 |
|
|
2020
Q3 | $2.01M | Sell |
110,837
-66,578
| -38% | -$1.21M | ﹤0.01% | 2488 |
|
|
2020
Q2 | $2.43M | Buy |
177,415
+15,886
| +10% | +$218K | ﹤0.01% | 2352 |
|
|
2020
Q1 | $2.31M | Buy |
161,529
+9,125
| +6% | +$130K | ﹤0.01% | 2218 |
|
|
2019
Q4 | $2.58M | Buy |
152,404
+45,245
| +42% | +$767K | ﹤0.01% | 2341 |
|
|
2019
Q3 | $1.65M | Buy |
107,159
+18,436
| +21% | +$284K | ﹤0.01% | 2447 |
|
|
2019
Q2 | $2.08M | Buy |
88,723
+2,035
| +2% | +$47.7K | ﹤0.01% | 2357 |
|
|
2019
Q1 | $2.46M | Buy |
86,688
+3,401
| +4% | +$96.4K | ﹤0.01% | 2293 |
|
|
2018
Q4 | $2.51M | Buy |
83,287
+10,634
| +15% | +$321K | ﹤0.01% | 2244 |
|
|
2018
Q3 | $2.55M | Buy |
72,653
+1,593
| +2% | +$55.8K | ﹤0.01% | 2353 |
|
|
2018
Q2 | $1.69M | Sell |
71,060
-5,082
| -7% | -$121K | ﹤0.01% | 2425 |
|
|
2018
Q1 | $1.95M | Buy |
76,142
+8,424
| +12% | +$216K | ﹤0.01% | 2341 |
|
|
2017
Q4 | $1.18M | Buy |
67,718
+7,957
| +13% | +$138K | ﹤0.01% | 2466 |
|
|
2017
Q3 | $1.65M | Buy |
+59,761
| New | +$1.65M | ﹤0.01% | 2352 |
|